Follow
HADI M. YASSINE
HADI M. YASSINE
Section Head of Research, Associate Professor of Infectious Diseases, IBC chair, Qatar University
Verified email at QU.edu.qa
Title
Cited by
Cited by
Year
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants
LJ Abu-Raddad, H Chemaitelly, AA Butt
New England Journal of Medicine 385 (2), 187-189, 2021
10812021
Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar
H Chemaitelly, P Tang, MR Hasan, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 385 (24), e83, 2021
8452021
Pre-fusion structure of a human coronavirus spike protein
RN Kirchdoerfer, CA Cottrell, N Wang, J Pallesen, HM Yassine, HL Turner, ...
Nature 531 (7592), 118-121, 2016
8062016
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
M Kanekiyo, CJ Wei, HM Yassine, PM McTamney, JC Boyington, ...
Nature 499 (7456), 102-106, 2013
8032013
Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
HM Yassine, JC Boyington, PM McTamney, CJ Wei, M Kanekiyo, ...
Nature medicine 21 (9), 1065-1070, 2015
6402015
Effects of previous infection and vaccination on symptomatic omicron infections
HN Altarawneh, H Chemaitelly, HH Ayoub, P Tang, MR Hasan, ...
New England Journal of Medicine 387 (1), 21-34, 2022
4382022
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
P Tang, MR Hasan, H Chemaitelly, HM Yassine, FM Benslimane, ...
Nature medicine 27 (12), 2136-2143, 2021
4382021
Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms
MK Smatti, FS Cyprian, GK Nasrallah, AA Al Thani, RO Almishal, ...
Viruses 11 (8), 762, 2019
4272019
Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2
N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ...
Viruses 12 (6), 582, 2020
4192020
Protection against the Omicron variant from previous SARS-CoV-2 infection
HN Altarawneh, H Chemaitelly, MR Hasan, HH Ayoub, S Qassim, ...
New England Journal of Medicine 386 (13), 1288-1290, 2022
3982022
mRNA-1273 COVID-19 vaccine effectiveness against the B. 1.1. 7 and B. 1.351 variants and severe COVID-19 disease in Qatar
H Chemaitelly, HM Yassine, FM Benslimane, HA Al Khatib, P Tang, ...
Nature medicine 27 (9), 1614-1621, 2021
3982021
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
JO Ngwuta, M Chen, K Modjarrad, MG Joyce, M Kanekiyo, A Kumar, ...
Science translational medicine 7 (309), 309ra162-309ra162, 2015
3612015
Effect of mRNA vaccine boosters against SARS-CoV-2 Omicron infection in Qatar
LJ Abu-Raddad, H Chemaitelly, HH Ayoub, S AlMukdad, HM Yassine, ...
New England Journal of Medicine 386 (19), 1804-1816, 2022
3582022
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
Q Fernandes, VP Inchakalody, M Merhi, S Mestiri, N Taib, ...
Annals of medicine 54 (1), 524-540, 2022
3222022
Evaluation of candidate vaccine approaches for MERS-CoV
L Wang, W Shi, MG Joyce, K Modjarrad, Y Zhang, K Leung, CR Lees, ...
Nature communications 6 (1), 7712, 2015
3152015
Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses
MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ...
Cell 166 (3), 609-623, 2016
2962016
Structural and genetic basis for development of broadly neutralizing influenza antibodies
D Lingwood, PM McTamney, HM Yassine, JRR Whittle, X Guo, ...
Nature 489 (7417), 566-570, 2012
2822012
Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting
Clinical Infectious Diseases, 2020
239*2020
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher, SF Andrews, ...
Nature immunology 20 (3), 362-372, 2019
2322019
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA. 1 and BA. 2 subvariants in Qatar
H Chemaitelly, HH Ayoub, S AlMukdad, P Coyle, P Tang, HM Yassine, ...
Nature communications 13 (1), 3082, 2022
2182022
The system can't perform the operation now. Try again later.
Articles 1–20